4//SEC Filing
Kelly Patrick F. 4
Accession 0000899243-20-017426
CIK 0001538927other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 7:26 PM ET
Size
5.6 KB
Accession
0000899243-20-017426
Insider Transaction Report
Form 4
Kelly Patrick F.
SVP, Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2020-06-18+116,890→ 0 totalExercise: $20.00Exp: 2030-06-17→ Common Stock (116,890 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the stock option shall vest on June 18, 2021 and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.
Documents
Issuer
Forma Therapeutics Holdings, Inc.,
CIK 0001538927
Entity typeother
Related Parties
1- filerCIK 0001814771
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 7:26 PM ET
- Size
- 5.6 KB